Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Epelde

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
International Journal of Chronic Obstructive Pulmonary Disease|September 9, 2017
Effect of a rehabilitation-based chronic disease management program targeting severe COPD exacerbations on readmission patternsC Lalmolda, R Coll-Fernández, N Martínez, et al.
European Journal of Clinical Investigation|April 26, 2003
Enalaprilat, losartan and LU 135252 in coronary blood flow regulationM Rigol, M Heras, N Solanes, et al.
European Journal of Clinical Investigation|February 1, 1997
Cocaine administration enhances platelet reactivity to subendothelial components: studies in a pig modelM J Zurbano, M Heras, M Rigol, et al.
Anales De Medicina Interna (Madrid, Spain : 1984)|June 22, 2000
[Assessment of the appropriate utilization of an emergency department observation unit with the Appropriateness Evaluation Protocol: analysis of 4,700 cases]S Tomás Vecina, E Duaso Magaña, J M Ferrer Tarres, et al.
Coronary Artery Disease|February 1, 1996
The role of endogenous nitric oxide in the response of coronary blood flow to tachycardiaM Heras, E Roig, F Pérez-Villa, et al.
Revista Espanola De Cardiologia|March 4, 2000
[Effect of cyclooxygenase inhibition on the adaptation of coronary blood flow to tachycardia]F Pérez-Villa, F Epelde, E Roig, et al.
Revista Espanola De Quimioterapia : Publicacion Oficial De La Sociedad Espanola De Quimioterapia|January 12, 2019
Factors associated with development of nephrotoxicity in patients treated with vancomycin versus daptomycin for severe Gram-positive infections: A practice-based studyJ Barberan, J Mensa, A Artero, et al.
Revista Clinica Espanola|March 13, 2022
Benefits of a comprehensive care model in patients with heart failure and preserved ejection fraction: The UMIPIC programJ M Cerqueiro-González, Á González-Franco, S Carrascosa-García, et al.
Revista Clinica Espanola|February 15, 2015
Spironolactone in patients with heart failure and preserved ejection fractionC Sánchez-Sánchez, H F Mendoza-Ruiz de Zuazu, F Formiga, et al.
Revista Clinica Espanola|October 11, 2021
Changes over time in the association between type 2 diabetes and post-discharge outcomes in decompensated chronic heart failure patients: Findings from the RICA RegistryF J Carrasco-Sánchez, M I Páez-Rubio, J C Arévalo-Lorido, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
International Journal of Chronic Obstructive Pulmonary Disease|September 9, 2017
Effect of a rehabilitation-based chronic disease management program targeting severe COPD exacerbations on readmission patternsC Lalmolda, R Coll-Fernández, N Martínez, et al.
European Journal of Clinical Investigation|April 26, 2003
Enalaprilat, losartan and LU 135252 in coronary blood flow regulationM Rigol, M Heras, N Solanes, et al.
European Journal of Clinical Investigation|February 1, 1997
Cocaine administration enhances platelet reactivity to subendothelial components: studies in a pig modelM J Zurbano, M Heras, M Rigol, et al.
Anales De Medicina Interna (Madrid, Spain : 1984)|June 22, 2000
[Assessment of the appropriate utilization of an emergency department observation unit with the Appropriateness Evaluation Protocol: analysis of 4,700 cases]S Tomás Vecina, E Duaso Magaña, J M Ferrer Tarres, et al.
Coronary Artery Disease|February 1, 1996
The role of endogenous nitric oxide in the response of coronary blood flow to tachycardiaM Heras, E Roig, F Pérez-Villa, et al.
Revista Espanola De Cardiologia|March 4, 2000
[Effect of cyclooxygenase inhibition on the adaptation of coronary blood flow to tachycardia]F Pérez-Villa, F Epelde, E Roig, et al.
Revista Espanola De Quimioterapia : Publicacion Oficial De La Sociedad Espanola De Quimioterapia|January 12, 2019
Factors associated with development of nephrotoxicity in patients treated with vancomycin versus daptomycin for severe Gram-positive infections: A practice-based studyJ Barberan, J Mensa, A Artero, et al.
Revista Clinica Espanola|March 13, 2022
Benefits of a comprehensive care model in patients with heart failure and preserved ejection fraction: The UMIPIC programJ M Cerqueiro-González, Á González-Franco, S Carrascosa-García, et al.
Revista Clinica Espanola|February 15, 2015
Spironolactone in patients with heart failure and preserved ejection fractionC Sánchez-Sánchez, H F Mendoza-Ruiz de Zuazu, F Formiga, et al.
Revista Clinica Espanola|October 11, 2021
Changes over time in the association between type 2 diabetes and post-discharge outcomes in decompensated chronic heart failure patients: Findings from the RICA RegistryF J Carrasco-Sánchez, M I Páez-Rubio, J C Arévalo-Lorido, et al.
Pageof 4